Fenel M. Eloi is Chief Operating Officer and Chief Financial Officer of Cell Signaling Technology (CST) and has been with the company since 2005. In his dual role, he is responsible for all commercial operations and all General & Administrative functions of the company. Prior to joining CST, Mr. Eloi was COO of Interleukin Genetics, a genetic diagnostic company. Prior to that, he was Senior Vice President and Chief Financial Officer for LifeCell Corporation, a tissue engineering company. Fenel is a builder. He spent the better part of his professional career working with management teams that have led small companies through transitions to mid and large size. Those transitions have been effected through a combination of organic growth and acquisitions. Fenel committed his career to working in the Life Sciences industry because he wanted his work to contribute to the betterment of life. Mr. Eloi has an M.B.A. from Anna Maria College in Paxton, Massachusetts, as well as a B.S. from Lee University in Cleveland, Tennessee and has served on a number of corporate boards.